SEQUESSOME TECHNOLOGY

WIPO WIPO 2011

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die Internationale Marke SEQUESSOME TECHNOLOGY wurde als Wortmarke am 20.12.2011 bei der Weltorganisation für geistiges Eigentum angemeldet.

Markendetails Letztes Update: 22. Dezember 2021

Markenform Wortmarke
Aktenzeichen 1121803
Registernummer 2586860
Länder Australien Bahrain Kanada Schweiz China Europäische Gemeinschaft Israel Iran Island Japan Kenia Südkorea Liechtenstein Monaco Norwegen Oman Singapur Türkei Vereinigte Staaten von Amerika (USA) Vietnam
Basismarke GB Nr. 2586860, 06. Juli 2011
Anmeldedatum 20. Dezember 2011
Ablaufdatum 20. Dezember 2031

Markeninhaber

4th floor,
Reading Bridge House,
GB

Markenvertreter

Bedford House, John Street London WC1N 2BF GB

Waren und Dienstleistungen

05 Pharmaceutical preparations and substances; veterinary and sanitary preparations and substances; chemical preparations for pharmaceutical purposes; pharmaceuticals in the field of osteoarthritis, oncology, cardiovascular disease, respiratory disease, inflammation, infection, gastrointestinal diseases and central nervous system diseases; diagnostic preparations for medical and veterinary use; topical and parenteral preparations of vesicles; chemical preparations in the form of vesicles for medical and veterinary purposes; chemical membranes and chemical aggregates for medical and veterinary purposes; preparations of arachidonic acids; dispersions and dry preparations of liposomal active substance carriers for pharmaceutical, cosmetic and veterinary substances; cosmeceutical preparations for medical use; anti-inflammatory drugs; lipids for topical and parenteral use; creams, dispersions, lotions, ointments, gels, solutions, sprays, lacquers and film forming solution for the treatment of pain or inflammation; surfactants for use in the treatment of or prevention of cancer, infectious disease, fungal diseases, disease caused by parasites, eye disease, diseases of the central and peripheral nervous systems, cardiovascular disease, diseases affecting the immune system, inflammatory diseases, inherited disease, single gene disorders, diseases of the mouth, teeth, skin, hair and ear, bone and blood diseases and reproductive system disorders, the treatment of inflammation, asthma, atopic eczema, dishydrotic hand eczema, plaque type psoriasis, seborrheic eczema, acne vulgaris, bronchospasm, atherothrombotic cardiovascular disorders, venous thrombotic disorders, pain, dysmenorrhea, hypercholesterolemia, hypertriglyceridemia, fatty acid metabolism, metal or other toxicity, alzheimer's disease, gout or macular degeneration, such as AMD, or fungal infection, and disorders related to fatty acid deficiencies
10 Medical devices for topical use in allowing subcutaneous absorption for the treatment of pain; molecular filtering devices for medical use; medical, veterinary and surgical apparatus, instruments and devices; apparatus, instruments and devices for dispensing medical, surgical and veterinary preparations, dispersions, creams, powders, tablets and pills; instruments and devices for the administration of therapy and prophylaxis preparations and substances; parts and fittings for all of the aforesaid
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

Markenhistorie

Datum Belegnummer Bereich Eintrag
20. Dezember 2021 2021/51 Gaz Verlängerung
15. September 2021 2021/39 Gaz CA RAW: Rule 18ter(2)(ii) GP following a provisional refusal
26. November 2020 2020/49 Gaz CA Ablehnung
15. August 2019 2019/33 Gaz Korrektur
05. August 2014 2014/34 Gaz SG RAW: Rule 18ter(2)(ii) GP following a provisional refusal
07. April 2014 2014/20 Gaz IL RAW: Rule 18ter(2)(i) GP following a provisional refusal
07. Februar 2014 2014/7 Gaz US RAW: Rule 18ter(2)(ii) GP following a provisional refusal
06. Februar 2014 2014/7 Gaz TR Ablehnung
30. September 2013 2013/42 Gaz KE Ablehnung
26. September 2013 2013/39 Gaz KR RAW: Rule 18ter(2)(ii) GP following a provisional refusal
06. August 2013 2013/33 Gaz IL Ablehnung
31. Juli 2013 2013/39 Gaz VN Ablehnung
31. Juli 2013 2013/35 Gaz SY Ablehnung
25. Juli 2013 2013/30 Gaz JP RAW: Rule 18ter(2)(ii) GP following a provisional refusal
12. Juli 2013 2013/32 Gaz CH Ablehnung
04. Juli 2013 2013/28 Gaz MD Ablehnung
04. Juni 2013 2013/23 Gaz EM Ablehnung
23. April 2013 2013/20 Gaz LI Ablehnung
15. April 2013 2013/16 Gaz CN Ablehnung
08. März 2013 2013/11 Gaz NO Ablehnung
31. Januar 2013 2013/5 Gaz JP Ablehnung
08. Januar 2013 2013/2 Gaz AU Ablehnung
27. Dezember 2012 2013/2 Gaz IS Ablehnung
18. Dezember 2012 2012/51 Gaz KR Ablehnung
02. November 2012 2013/42 Gaz MC Ablehnung
30. Oktober 2012 2012/45 Gaz SG Ablehnung
10. August 2012 2012/33 Gaz US Ablehnung
20. Dezember 2011 2012/29 Gaz GB Eintragung
Teilweise Löschung

ID: 141121803